Invesco Ltd.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 914208 Atlanta, GA

Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,457,162,245

+$1,124,761,576 QoQ

Shares Held

3,940,665

+128.5% QoQ

Ownership

3.83%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

of 1,322 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 0% Shared 99% None 1%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. REGN ranks #2 (17.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,043,052	$3,995,225,212
2	REGN	Regeneron Pharmaceuticals, Inc. This page	3,940,665	$2,457,162,245
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,754,318	$1,130,162,341
4	INCY	Incyte Corp	4,080,461	$462,561,050
5	ARGX	Argenx SE	443,990	$411,920,598
6	AXSM	Axsome Therapeutics, Inc.	1,671,684	$409,178,086
7	MRNA	Moderna, Inc.	5,780,299	$404,794,337
8	LGND	Ligand Pharmaceuticals Inc	1,201,644	$379,827,645

All Filings in REGN

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,457,162,245	3,940,665	+128.5%	Shares	Defined	2026-08-14
2026-03-31	$1,332,400,669	1,724,478	+8.4%	Shares	Defined	2026-05-12
2025-12-31	$1,228,126,204	1,591,105	+7.2%	Shares	Defined	2026-02-19
2025-09-30	$834,674,626	1,484,473	+38.0%	Shares	Defined	2025-11-13
2025-06-30	$564,807,600	1,075,824	+26.5%	Shares	Defined	2025-08-13
2025-03-31	$539,568,628	850,746	-1.6%	Shares	Defined	2025-05-12
2024-12-31	$615,630,482	864,249	-25.6%	Shares	Defined	2025-02-13
2024-09-30	$1,220,671,495	1,161,173	+26.7%	Shares	Defined	2024-11-12
2024-06-30	$963,184,902	916,420	-7.1%	Shares	Defined	2024-08-13
2024-03-31	$949,080,581	986,068	+28.9%	Shares	Defined	2024-05-14
2023-12-31	$671,897,989	765,007	+2.9%	Shares	Defined	2024-02-13
2023-09-30	$611,745,661	743,348	-18.2%	Shares	Sole	2023-11-13
2023-06-30	$653,197,400	909,062	+2.7%	Shares	Defined	2023-08-11
2023-03-31	$726,976,631	884,755	+27.7%	Shares	Defined	2023-05-12
2022-12-31	$499,893,716	692,863	+8.0%	Shares	Defined	2023-02-13
2022-09-30	$441,787,477	641,322	+2.1%	Shares	Defined	2022-11-14
2022-06-30	$371,340,174	628,187	+4.2%	Shares	Defined	2022-08-15
2022-03-31	$421,099,061	602,931	+2.5%	Shares	Defined	2022-05-16
2021-12-31	$371,467,004	588,211	+21.4%	Shares	Defined	2022-02-14
2021-09-30	$293,172,183	484,438	+5.7%	Shares	Defined	2021-11-15
2021-06-30	$256,079,413	458,480	-2.3%	Shares	Defined	2021-08-17
2021-03-31	$222,065,414	469,344	+17.8%	Shares	Defined	2021-05-17
2020-12-31	$192,500,487	398,461	+37.3%	Shares	Defined	2021-02-16
2020-09-30	$162,474,459	290,247	+12.0%	Shares	Defined	2020-11-16
2020-06-30	$161,605,169	259,128	-14.3%	Shares	Defined	2020-08-14
2020-03-31	$147,724,807	302,535	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.